To make such a system robust, we’ll need a mechanism in place to test specimens for a novel pathogen even if we don’t have the explicit permission from the patients who gave those samples. Rules governing informed consent should be amended to address a declared public health emergency. We need to safeguard privacy concerns and make sure results are shared confidentially. But the imperative is to rapidly identify emerging outbreaks with novel pathogens.

